loading page

SARS-CoV-2 and Recent Therapeutics: A Current Scenario
  • Vishal Chavda,
  • Kajal Madhvani,
  • Snehal Patel
Vishal Chavda
Nirma University Institute of Pharmacy
Author Profile
Kajal Madhvani
Nirma University Institute of Science
Author Profile
Snehal Patel
Nirma University of Science and Technology Institute of Pharmacy, Nirma University
Author Profile


SARS-CoV-2 is the pandemic affecting the life worldwide and increasing the day to day morbidity and mortality. The virus has started its presence from December 2019 and till date many people are affected in larger numbers as there is no specific pathology or pathogenesis available. Moreover, few drugs have shown their potential as effective therapy in early stages of this viral infection. Many drugs are under clinical trials and many countries are in a race to develop vaccination for this rapidly growing infection. In this review, we have tried to focus the revealed pathology, available new targets, and future scope of therapeutic candidates for this deadly infection. This review focuses on key aspects of origin, transmission, etiology, and progress on available tools for clinical diagnostics. We have also tried to enlighten the drug candidates for strong future therapeutic targets for this deadly infection. In short, this review briefly discusses the hopes and hypes of SARS-CoV-19 infection, its related current therapeutics, and recent advancements in SARS-CoV-19 treatment.